Amir Reichman
Fortune : 42 550 $ au 30/06/2026
Fortune : 42 550 $ au 30/06/2026
Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 67 540 000 ( 0,34 % ) | 42 550 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Directeur Général | 02/03/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Corporate Officer/Principal | 01/03/2021 |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01/01/2015 |
| NEURODERM LTD | Fondateur | 01/01/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national